Caricamento...
Clinical Utility of Glatiramer Acetate in the Management of Relapse Frequency in Multiple Sclerosis
Glatiramer acetate (GA) represents one of the most common disease-modifying therapies for multiple sclerosis. GA is currently approved for patients at high risk of developing clinically definite multiple sclerosis (CDMS) after having experienced a well-defined first clinical episode (clinically isol...
Salvato in:
| Autore principale: | |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Libertas Academica
2012
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3619555/ https://ncbi.nlm.nih.gov/pubmed/23650472 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4137/JCNSD.S8755 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|